000788 Stock Overview
Researches, develops, manufactures, and sells pharmaceutical products in China. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
PKU HealthCare Corp.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥6.11 |
52 Week High | CN¥7.35 |
52 Week Low | CN¥4.04 |
Beta | 0.33 |
11 Month Change | 0.83% |
3 Month Change | 17.05% |
1 Year Change | -15.72% |
33 Year Change | -5.56% |
5 Year Change | -7.00% |
Change since IPO | 52.84% |
Recent News & Updates
Shareholder Returns
000788 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -1.5% | -1.5% | -2.1% |
1Y | -15.7% | -9.4% | 2.8% |
Return vs Industry: 000788 underperformed the CN Pharmaceuticals industry which returned -4.8% over the past year.
Return vs Market: 000788 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
000788 volatility | |
---|---|
000788 Average Weekly Movement | 6.0% |
Pharmaceuticals Industry Average Movement | 7.3% |
Market Average Movement | 8.3% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 000788 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000788's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1965 | 797 | Ping Dong Yuan | www.pku-hc.com |
PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, psychoneurological, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion.
PKU HealthCare Corp.,Ltd. Fundamentals Summary
000788 fundamental statistics | |
---|---|
Market cap | CN¥3.64b |
Earnings (TTM) | CN¥128.57m |
Revenue (TTM) | CN¥2.07b |
28.3x
P/E Ratio1.8x
P/S RatioIs 000788 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
000788 income statement (TTM) | |
---|---|
Revenue | CN¥2.07b |
Cost of Revenue | CN¥1.48b |
Gross Profit | CN¥588.17m |
Other Expenses | CN¥459.60m |
Earnings | CN¥128.57m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.22 |
Gross Margin | 28.38% |
Net Profit Margin | 6.20% |
Debt/Equity Ratio | 0% |
How did 000788 perform over the long term?
See historical performance and comparison